Search

everythinglearnresearchcommunity

for

Search:↓

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Certain growth factors can promote hair growth in mice by activating hair growth-related proteins.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Topical JAK inhibitors may help treat some skin conditions but need more research.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Minoxidil promotes hair growth by increasing cell division and DNA synthesis.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

RTA 408 cream protects mice from radiation skin damage.

Using CRISPR for gene editing in the body is promising but needs better delivery methods to be more efficient and specific.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Semecarpus anacardium Linn. has many medicinal benefits.

Both mouse and rat models are effective for testing alopecia areata treatments.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.